摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-<2-(3-methoxyphenyl)ethyl>(3-hydroxy-4-methoxyphenyl)acetamide | 74007-21-9

中文名称
——
中文别名
——
英文名称
N-<2-(3-methoxyphenyl)ethyl>(3-hydroxy-4-methoxyphenyl)acetamide
英文别名
2-(3-hydroxy-4-methoxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide;N-(3-Methoxy-phenethyl)-3-hydroxy-4-methoxy-phenylacetamid;3-Hydroxy-4-methoxy-N-[2-(3-methoxyphenyl)ethyl]benzeneacetamide
N-<2-(3-methoxyphenyl)ethyl>(3-hydroxy-4-methoxyphenyl)acetamide化学式
CAS
74007-21-9
化学式
C18H21NO4
mdl
——
分子量
315.369
InChiKey
OMDAQWLOORIMIZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    100-101 °C
  • 沸点:
    570.6±50.0 °C(Predicted)
  • 密度:
    1.175±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    23
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    67.8
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Preparation of amides from an acid and amine for intermediates in the synthesis of morphinans
    申请人:Mallinckrodt Inc.
    公开号:EP2177504A1
    公开(公告)日:2010-04-21
    The present invention is directed to processes for the synthesis of morphinans. In particular, a process for coupling a carboxylic acid compound with an amine compound to form an amide product that can then be isolated or the crude amide product can be cyclized to form a 3,4-dihydroisoquinoline. In one embodiment, the carboxylic acid contains a phenol moiety protected with a labile protecting group. The protected phenol reduces reaction times, simplifies work-up of the product, and reduces the amount of cyclizing agent, POCl3 that is necessary to form the 3,4-dihydroisoquinoline.
    本发明涉及吗啡类化合物的合成工艺。特别是一种将羧酸化合物与胺化合物偶联形成酰胺产物的工艺,该酰胺产物可以分离出来,或者将粗酰胺产物环化形成3,4-二氢异喹啉。在一个实施方案中,羧酸含有一个用易变保护基团保护的苯酚分子。受保护的苯酚可缩短反应时间,简化产品的加工,并减少形成 3,4-二氢异喹啉所需的环化剂 POCl3 的用量。
  • Process for the preparation of 3,4-dihydroisoquinolines in the synthesis of morphinans
    申请人:Mallinckrodt Inc.
    公开号:EP2161253A2
    公开(公告)日:2010-03-10
    The present invention is directed to processes for the synthesis of morphinans. In particular, a process tor coupling a carboxylic acid compound with an amine compound to form an amide product that can then be isolated or the crude amide product can be cyclized to form a 3,4-dihydroisoquinoline. In one embodiment, the carboxylic acid contains a phenol moiety protected with a labile protecting group. The protected phenol reduces reaction times, simplifies work-up of the product, and reduces the amount of cyclizing agent, POCl3 that is necessary to form the 3,4-dihydroisoquinoline.
    本发明涉及吗啡类化合物的合成工艺。特别是一种将羧酸化合物与胺化合物偶联形成酰胺产物的工艺,这种酰胺产物可以分离出来,或者将粗酰胺产物环化形成 3,4-二氢异喹啉。在一个实施方案中,羧酸含有一个用易变保护基团保护的苯酚分子。受保护的苯酚可缩短反应时间,简化产品的加工,并减少形成 3,4-二氢异喹啉所需的环化剂 POCl3 的用量。
  • Meuzelaar, Gerrit J.; Van Vliet, Michiel C. A.; Maat, Leendert, European Journal of Organic Chemistry, 1999, # 9, p. 2315 - 2321
    作者:Meuzelaar, Gerrit J.、Van Vliet, Michiel C. A.、Maat, Leendert、Sheldon, Roger A.
    DOI:——
    日期:——
  • A New Class of Selective and Potent 7-Dehydrocholesterol Reductase Inhibitors
    作者:Aline Horling、Christoph Müller、Richard Barthel、Franz Bracher、Peter Imming
    DOI:10.1021/jm3006096
    日期:2012.9.13
    We prepared a number of N-phenethyltetrahydroisoquinolines structurally related to protoberberines. They were tested for activity against bacteria, fungi, and human leukemia HL-60 cells and also for inhibition of biosynthesis: ergosterol in yeasts and cholesterol in human cells. In the latter assay panel, several of the compounds were distinguished by a strong and selective inhibition of 7-dehydrocholesterol reductase (7-DHCR, EC 1.3.1.21), an enzyme responsible for the conversion of 7-dehydrocholesterol to cholesterol in the last step of cholesterol biosynthesis. In a whole-cell assay, the most active compound 5f showed a much stronger inhibition of overall cholesterol biosynthesis (IC50 2.3 nM) than BM 15.766 (IC50 500 nM), presently the most selective known inhibitor of 7-DHCR Since a defect of 7-dehydrocholesterol reductase is associated with Smith-Lemli-Opitz syndrome (SLOS), the potent and selective inhibitors reported here will enable more detailed investigation of the pathogenesis of SLOS.
  • WO2008/73390
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多